Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue SUPPL. 1, 2004, Pages 1219-1220

  Clark, Rebecca A ^a   Theall, Katherine ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ETHINYLESTRADIOL; INDINAVIR; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

HUMAN; LETTER; ORAL CONTRACEPTION; POPULATION RESEARCH; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CONTRACEPTION; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; ETHINYL ESTRADIOL; FEMALE; HIV INFECTIONS; HUMANS; NORETHINDRONE; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT FAILURE;

EID: 4444253052     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000136724.15758.ae     Document Type: Letter

References (1)

1. Department of Health and Human Services (DHHS). Guidelines for use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: http://AIDSinfo.nih.gov.